| Dorcas N Muiru, DNP-C | |
|
2100 N Main St Ste 304, Crown Point, IN 46307-1877 | |
| (413) 200-7168 | |
| Not Available |
| Full Name | Dorcas N Muiru |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2100 N Main St Ste 304, Crown Point, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336856764 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 71013258A (Indiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 71013258A (Indiana) | Primary |
| Entity Name | Neurology And Pain Management Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518900620 PECOS PAC ID: 4486676095 Enrollment ID: O20051223000201 |
News Archive
People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't been a good way to determine whether this transformation to cancer has happened.
As parts of us age, even the membrane bound nuclei , which house the genetic instructions for life that are "written" in our DNA, begin to show considerable wear and tear, suggests a new report in the January 23rd issue of the journal Cell, a Cell Press publication.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.
Kentucky firefighter Jimmy Adams saw the ravages of the coronavirus pandemic when he served as a medic who helped care for the sick on medical calls amid surging covid cases.
HealthGrades, the leading provider of information to help consumers make an informed decision about a physician or hospital and CPM, the leading provider of customer relationship management solutions for hospitals today announced a definitive agreement to merge the two companies.
› Verified 6 days ago
| Entity Name | Pinnacle Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922546530 PECOS PAC ID: 1254331184 Enrollment ID: O20080430000005 |
News Archive
People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't been a good way to determine whether this transformation to cancer has happened.
As parts of us age, even the membrane bound nuclei , which house the genetic instructions for life that are "written" in our DNA, begin to show considerable wear and tear, suggests a new report in the January 23rd issue of the journal Cell, a Cell Press publication.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.
Kentucky firefighter Jimmy Adams saw the ravages of the coronavirus pandemic when he served as a medic who helped care for the sick on medical calls amid surging covid cases.
HealthGrades, the leading provider of information to help consumers make an informed decision about a physician or hospital and CPM, the leading provider of customer relationship management solutions for hospitals today announced a definitive agreement to merge the two companies.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dorcas N Muiru, DNP-C 303 S Main St Ste 109, Mishawaka, IN 46544-2159 Ph: (574) 256-0235 | Dorcas N Muiru, DNP-C 2100 N Main St Ste 304, Crown Point, IN 46307-1877 Ph: (413) 200-7168 |
News Archive
People with an inherited condition known as neurofibromatosis type 1, or NF1, often develop non-cancerous, or benign, tumors that grow along nerves. These tumors can sometimes turn into aggressive cancers, but there hasn't been a good way to determine whether this transformation to cancer has happened.
As parts of us age, even the membrane bound nuclei , which house the genetic instructions for life that are "written" in our DNA, begin to show considerable wear and tear, suggests a new report in the January 23rd issue of the journal Cell, a Cell Press publication.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced that it has received a Phase 1 Small Business Innovation Research Grant (SBIR) from the National Institute of Allergy and Infectious Disease (NIAID) branch of the National Institutes of Health (NIH) for the further study and characterization of a back-up series of compounds related to its novel antibacterial, ACH-702.
Kentucky firefighter Jimmy Adams saw the ravages of the coronavirus pandemic when he served as a medic who helped care for the sick on medical calls amid surging covid cases.
HealthGrades, the leading provider of information to help consumers make an informed decision about a physician or hospital and CPM, the leading provider of customer relationship management solutions for hospitals today announced a definitive agreement to merge the two companies.
› Verified 6 days ago